Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.66 | $4.28 | 8.97% | 35.85x | 19.42x | 10.64x | 19.94x | 0.38x | -$74.32M | -4.44% | $83.79M | 0.23 | $1.75B | 42.92 | ||
| CORT | CORCEPT THERAPEUTICS INC | $73.71 | $39.63 | 85.98% | 48.81x | 34.71x | 8.16x | 9.68x | 0.67x | $194.62M | 2.48% | $833.74M | 7.82 | $7.98B | 71.92 | ||
| TGTX | TG THERAPEUTICS INC | $64.56 | $20.43 | 215.94% | 82.77x | 62.98x | 10.12x | 17.06x | 1.15x | $85.56M | 0.94% | $572.13M | 4.06 | $10.08B | 51.34 | ||
| RPRX | ROYALTY PHARMA PLC | $68.97 | $34.94 | 97.37% | 45.08x | 12.61x | 11.76x | 4.04x | 0.74x | $2.89B | 9.41% | $9.80B | 21.96 | $47.64B | 45.65 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $316.27 | $72.82 | 334.32% | 119.35x | 32.61x | 24.87x | 6.58x | 1.56x | $90.43M | 1.43% | $961.76M | 48.18 | $7.42B | 75.38 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.53 | $7.97 | 245.59% | 125.14x | 88.86x | 7.09x | 14.27x | 1.18x | $59.71M | 1.66% | $243.97M | 1.86 | $3.56B | 76.14 | ||
| KRYS | KRYSTAL BIOTECH INC | $305.68 | $76.98 | 297.07% | 39.91x | 39.01x | 19.26x | 6.31x | 2.21x | $310.08M | 3.43% | $1.44B | 48.48 | $8.60B | 32.40 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $96.28 | $14.55 | 561.49% | 67.33x | 73.37x | 7.96x | 10.65x | 3.64x | $197.20M | 2.62% | $710.19M | 9.08 | $7.49B | 49.28 | ||
| ADMA | ADMA BIOLOGICS INC | $13.24 | $6.89 | 92.18% | 16.76x | 16.43x | 5.70x | 6.70x | 1.23x | $132.91M | 4.49% | $438.51M | 1.96 | $3.01B | 11.92 | ||
| HALO | HALOZYME THERAPEUTICS INC | $100.67 | $74.64 | 34.88% | 23.74x | 11.11x | 6.36x | -207.78x | 0.55x | $885.88M | 7.73% | -$55.24M | -0.49 | $13.70B | 17.00 | ||
| VCEL | VERICEL CORP | $57.42 | $8.51 | 574.90% | 87.00x | 76.07x | 9.07x | 7.63x | 3.15x | $57.89M | 1.97% | $384.17M | 7.51 | $2.89B | 53.54 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $240.37 | $130.26 | 84.53% | 66.04x | 15.73x | 3.30x | 3.68x | 0.63x | $1.65B | 10.63% | $4.19B | 64.79 | $19.02B | 16.60 | ||
| INCY | INCYTE CORP | $121.70 | $53.12 | 129.09% | 58.23x | 35.26x | 4.12x | 4.40x | 0.84x | $684.87M | 2.77% | $5.64B | 27.76 | $21.56B | 24.04 | ||
| EXEL | EXELIXIS INC | $69.84 | $31.47 | 121.90% | 20.24x | 19.95x | 6.90x | 9.29x | 1.36x | $1.16B | 6.74% | $1.83B | 7.43 | $16.90B | 15.12 | ||
| TECH | BIO-TECHNE CORP | $72.84 | $16.11 | 352.16% | 66.22x | 35.07x | 9.30x | 5.28x | 1.98x | $308.20M | 2.70% | $2.17B | 13.81 | $11.38B | 34.09 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.16 | $7.91 | 41.17% | 8.79x | 9.77x | 4.49x | 2.78x | 1.69x | $87.07M | 13.14% | $238.92M | 4.02 | $543.15M | 5.65 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $542.62 | $145.03 | 274.14% | 34.63x | 29.20x | 10.62x | 6.58x | 2.25x | $3.20B | 2.33% | $20.91B | 82.48 | $139.07B | 27.62 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $951.19 | $488.06 | 94.89% | 20.23x | 13.54x | 5.73x | 2.94x | 1.06x | $3.83B | 3.96% | $33.50B | 329.39 | $97.45B | 15.60 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.80 | $28.26 | 19.59% | 10.94x | 8.81x | 2.00x | 1.85x | 0.73x | $322.93M | 16.36% | $1.07B | 18.36 | $1.49B | 5.48 | ||
| UTHR | UNITED THERAPEUTICS CORP | $593.31 | $210.07 | 182.43% | 20.77x | 22.16x | 7.95x | 4.03x | 2.31x | $867.20M | 3.42% | $6.28B | 146.98 | $24.08B | 14.90 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $1.95 | $6.31 | -69.18% | 3.30x | -47.67x | N/A | 1.50x | 0.16x | -$21.06M | -5.86% | $139.32M | 0.76 | $201.98M | 160.69 | ||
| VCYT | VERACYTE INC | $24.63 | $9.64 | 155.43% | 15.49x | 12.58x | 3.41x | 1.39x | 3.32x | $161.95M | 8.17% | $1.43B | 17.80 | $1.83B | 12.81 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.